Targazyme Presents TZ-102 Cancer Immunotherapy Preclinical Results at the World Orphan Drug CongressGlobeNewswire (press release)CARLSBAD, Calif., April 26, 2018 (GLOBE NEWSWIRE) — Targazyme, Inc. a late clinical-stage biopharmaceutical company develo… Continue reading
Cronkite NewsGene therapy targets incurable diseasesCronkite NewsPHOENIX — Gene therapy could be the key to curing rare and life-threatening diseases but potential negative effects and costs are slowing the fledgling field, experts say. Gene therapy re… Continue reading
The Guardian |
NHS preparing to offer ‘game-changing’ cancer treatment
The Guardian The treatments, which are hugely expensive, work by genetically engineering the patient’s immune system’s killer T–cells to recognise and destroy cancer cells. In trials, they have had extraordinary success, putting into remission patients who had only … NHS set to offer cancer patients a ‘game changer’ treatment that could save THOUSANDS of livesDaily Mail Pioneering cancer therapy to be made available to NHS patientsThe Irish News |
AOL UK |
Pioneering cancer therapy to be made available to NHS patients
AOL UK A charity has welcomed news that a pioneering therapy that uses a patient’s own genetically modified cells to fight cancer will be made available to NHS patients. Chimeric antigen receptor T–cell therapy (CAR-T) will be “one of the most innovative … New CAR-T therapy could provide safer, more effective cancer …Brinkwire (press release) |